<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tab3" orientation="portrait" position="float">
 <label>Table 3</label>
 <caption>
  <p>Biological activities of some compounds from 
   <italic>Quercus</italic> species.
  </p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="left" rowspan="1" colspan="1">No</th>
    <th align="center" rowspan="1" colspan="1">Compound name</th>
    <th align="center" rowspan="1" colspan="1">Biological activity</th>
    <th align="center" rowspan="1" colspan="1">Description</th>
    <th align="center" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">1</td>
    <td align="center" rowspan="1" colspan="1">Polydatin</td>
    <td align="center" rowspan="1" colspan="1">Dermatological disorders</td>
    <td align="center" rowspan="1" colspan="1">Showed potent tyrosinase inhibition compared to the positive control, kojic acid, with an IC50 value of 4.05 ± 0.30 
     <italic>µ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B83" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">2</td>
    <td align="center" rowspan="1" colspan="1">(-)-8-Chlorocatechin</td>
    <td align="center" rowspan="1" colspan="1">Antidiabetic</td>
    <td align="center" rowspan="1" colspan="1">The most potent isolate, also more potent than the positive control, acarbose, with an IC50 value of 43.60 ± 0.67 
     <italic>µ</italic>g/mL
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B83" ref-type="bibr">83</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">3</td>
    <td align="center" rowspan="1" colspan="1">
     <italic>β</italic>-Sitosterol-D-glucoside
    </td>
    <td align="left" rowspan="1" colspan="1"> </td>
    <td align="center" rowspan="1" colspan="1">Showed moderate inhibitory activity against 
     <italic>α</italic>-glucosidase
    </td>
    <td align="left" rowspan="1" colspan="1"> </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">4</td>
    <td align="center" rowspan="1" colspan="1">Tiliroside</td>
    <td align="center" rowspan="1" colspan="1">Antidiabetic</td>
    <td align="center" rowspan="1" colspan="1">Highest 
     <italic>α</italic>-glucosidase inhibitory activity with an IC50 of 28.36 ± 0.11 mmol/L
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B86" ref-type="bibr">86</xref>, 
     <xref rid="B91" ref-type="bibr">91</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">5</td>
    <td align="center" rowspan="1" colspan="1">Epicatechin</td>
    <td align="center" rowspan="1" colspan="1">Antioxidant</td>
    <td align="center" rowspan="1" colspan="1">Higher antioxidant activity with inhibitory concentrations (IC50) of 22.55 ± 2.23 mmol/L than that of quercetin, which was used as the standard, with an IC50 of 28.08 ± 2.39 mmol/L</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B86" ref-type="bibr">86</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">6</td>
    <td align="center" rowspan="1" colspan="1">
     <bold>A</bold>-3-O-Galloyloleanolic acid-23-acetoxy-3-O-galloyloleanolic acid
     <break/>
     <bold>B</bold>-3-Acetoxy-23-O-galloyloleanolic acid
     <break/>
     <bold>C</bold>-3-O-Galloylursolic acid
    </td>
    <td align="center" rowspan="1" colspan="1">Antidiabetic</td>
    <td align="center" rowspan="1" colspan="1">Most of the compounds showed strong inhibitory effects on PTP1B and 
     <italic>α</italic>-glucosidase, their IC50 values were about 6-fold to 20-fold lower than positive control
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B49" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">7</td>
    <td align="center" rowspan="1" colspan="1">Quercetin-3-O-(2″-O-galloyl)-
     <italic>β</italic>-galactopyranoside
    </td>
    <td align="center" rowspan="1" colspan="1">Antidiabetic</td>
    <td align="center" rowspan="1" colspan="1">Increased the survival of pancreatic beta cells by reducing the production of reactive oxygen species and enhancing the activities of superoxide dismutase, catalase, and glutathione in MIN6 cells damaged by H
     <sub>2</sub>O
     <sub>2</sub>. The preliminary mechanism by which the compound protects pancreatic beta cells was through the nuclear factor erythroid-2-related factor 2 (Nrf
     <sub>2</sub>)/heme oxygenase-1 HO-1 pathway
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B87" ref-type="bibr">87</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">8</td>
    <td align="center" rowspan="1" colspan="1">Betulin</td>
    <td align="center" rowspan="1" colspan="1">Anticancer</td>
    <td align="center" rowspan="1" colspan="1">Treatment with betulin increases expression of the caspase family (i.e., caspase-3, -6, and -9), proapoptotic genes (BAX and BAK), and inhibiting antiapoptotic genes (BCL-2L1 and p53) and could also regulate metastasis by inhibiting MMP-2/-</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B29" ref-type="bibr">29</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">9</td>
    <td align="center" rowspan="1" colspan="1">Roburgenic acid</td>
    <td align="center" rowspan="1" colspan="1">Cytotoxicity</td>
    <td align="center" rowspan="1" colspan="1">Roburgenic acid was the most active compound (IC50 = 19.7 
     <italic>μ</italic>M) reaching a comparable value to those of positive controls
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B90" ref-type="bibr">90</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">10</td>
    <td align="center" rowspan="1" colspan="1">3-O-Galloyloleanolic acid</td>
    <td align="center" rowspan="1" colspan="1">Antihepatic fibrosis and antioxidant</td>
    <td align="center" rowspan="1" colspan="1">Upregulated the expression levels of Nrf
     <sub>2</sub> and HO-1 in t-HSC/Cl-6 cells
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B49" ref-type="bibr">49</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">11</td>
    <td align="center" rowspan="1" colspan="1">
     <bold>A</bold>-23-O-Galloyl-2
     <italic>α</italic>,3
     <italic>β</italic>,19
     <italic>α</italic>-trihydroxyurs-12-en- 28-oic acid 28-O-
     <italic>β</italic>-D-glucopyranoside
     <break/>
     <bold>B</bold>-3-O-Galloyl-2
     <italic>α</italic>,19
     <italic>α</italic>,23 trihydroxyurs-12-en-28-oic acid 28-O-
     <italic>β</italic>-D-glucopyranoside
     <break/>
     <bold>C</bold>-3,23-O-Butylidene 2
     <italic>α</italic>,3
     <italic>β</italic>,19
     <italic>α</italic>,23 tetrahydroxyolean-12-en-28-oic acid 28-O-
     <italic>β</italic>-D-glucopyranoside
     <break/>
     <bold>D</bold>-2
     <italic>α</italic>,3
     <italic>β</italic>,23-Trihydroxylup-20(29)-en-28-oic acid 28- O-
     <italic>β</italic>-D-glucopyranoside
    </td>
    <td align="center" rowspan="1" colspan="1">Antineuroinflammatory</td>
    <td align="center" rowspan="1" colspan="1">The compounds reduce dose dependently the expression levels of proinflammatory mediator iNOS and reduce the COX-2 expression induced by LPS in BV-2 cells</td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B45" ref-type="bibr">45</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">12</td>
    <td align="center" rowspan="1" colspan="1">
     <bold>A</bold>-3,23-O-Methyl butyrate 2,3,19,23-tetrahydroxy-urs-12-en-28-oic acid -d glucopyranosyl ester
     <break/>
     <bold>B</bold>-3,23-O-Methyl butyrate-2,3,19,23-tetrahydroxy-olean-12-en-28-oic acid -d-glucopyranosyl ester
     <break/>
     <bold>C</bold>-23-Acetoxy-2,3,19 trihydroxyurs-12-en-28-oic acid
    </td>
    <td align="center" rowspan="1" colspan="1">Anti-inflammatory</td>
    <td align="center" rowspan="1" colspan="1">The three compounds showed pronounced anti-inflammatory activities compared to positive control indomethacin (IC50 (
     <italic>µ</italic>M): 8.2 ± 0.6, 12.8 ± 0.8, 19.1 ± 6.1, and 47.4 ± 4.5, respectively) and higher activity against proinflammatory cytokines (IL-6 and IL-8)
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B44" ref-type="bibr">44</xref>]
    </td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">13</td>
    <td align="center" rowspan="1" colspan="1">
     <bold>A</bold>-(-)-Epicatechin
     <break/>
     <bold>B</bold>-Procyanidin B3
     <break/>
     <bold>C</bold>-Procyanidin B4
    </td>
    <td align="center" rowspan="1" colspan="1">Anti-inflammatory</td>
    <td align="center" rowspan="1" colspan="1">The three compounds showed dose-dependent inhibitory activities on gene expression of COX-2 and IL-1
     <italic>β</italic>
    </td>
    <td align="center" rowspan="1" colspan="1">[
     <xref rid="B80" ref-type="bibr">80</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
